These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9624494)

  • 1. Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
    Franceschini N; Perilli M; Segatore B; Setacci D; Amicosante G; Mazzariol A; Cornaglia G
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1459-62. PubMed ID: 9624494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam.
    Piccirilli A; Perilli M; Amicosante G; Conte V; Tascini C; Rossolini GM; Giani T
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
    Poirel L; Mammeri H; Nordmann P
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4528-31. PubMed ID: 15561821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
    Livermore DM; Yuan M
    J Antimicrob Chemother; 1996 Sep; 38(3):409-24. PubMed ID: 8889716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations.
    Luzzaro F; Perilli M; Amicosante G; Lombardi G; Belloni R; Zollo A; Bianchi C; Toniolo A
    Int J Antimicrob Agents; 2001 Feb; 17(2):131-5. PubMed ID: 11165117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
    Arlet G; Rouveau M; Fournier G; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2020-3. PubMed ID: 8239625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.
    Kitzis MD; Billot-Klein D; Goldstein FW; Williamson R; Tran Van Nhieu G; Carlet J; Acar JF; Gutmann L
    Antimicrob Agents Chemother; 1988 Jan; 32(1):9-14. PubMed ID: 2831817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
    Rice LB; Carias LL; Hujer AM; Bonafede M; Hutton R; Hoyen C; Bonomo RA
    Antimicrob Agents Chemother; 2000 Feb; 44(2):362-7. PubMed ID: 10639363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
    Thomson CJ; Amyes SG
    J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
    Philippon LN; Naas T; Bouthors AT; Barakett V; Nordmann P
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
    Berrazeg M; Jeannot K; Ntsogo Enguéné VY; Broutin I; Loeffert S; Fournier D; Plésiat P
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6248-55. PubMed ID: 26248364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First characterization of a Providencia stuartii clinical isolate from a Tunisian intensive care unit coproducing VEB-1-a, OXA-2, qnrA6 and aac(6')-Ib-cr determinants.
    Mahrouki S; Chihi H; Bourouis A; Ben Moussa M; Belhadj O
    Braz J Infect Dis; 2014; 18(2):211-4. PubMed ID: 24378226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.
    Pillar CM; Stoneburner A; Shinabarger DL; Krause KM; Nichols WW
    Lett Appl Microbiol; 2016 Aug; 63(2):96-102. PubMed ID: 27221329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First detection of TEM-116 extended-spectrum β-lactamase in a Providencia stuartii isolate from a Tunisian hospital.
    Lahlaoui H; Dahmen S; Moussa MB; Omrane B
    Indian J Med Microbiol; 2011; 29(3):258-61. PubMed ID: 21860106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor.
    Bonnefoy A; Dupuis-Hamelin C; Steier V; Delachaume C; Seys C; Stachyra T; Fairley M; Guitton M; Lampilas M
    J Antimicrob Chemother; 2004 Aug; 54(2):410-7. PubMed ID: 15254025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases.
    Caniça MM; Barthélémy M; Gilly L; Labia R; Krishnamoorthy R; Paul G
    Antimicrob Agents Chemother; 1997 Feb; 41(2):374-8. PubMed ID: 9021194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
    Tajada P; Gomez-Graces JL; Alós JI; Balas D; Cogollos R
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1924-5. PubMed ID: 8843305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.